home / stock / cstl / cstl news

CSTL News and Press, Castle Biosciences Inc. From 12/09/25

Stock Information
Company Name: Castle Biosciences Inc.
Stock Symbol: CSTL
Market: NASDAQ
Website: castlebiosciences.com
Menu
CSTL CSTL Quote CSTL Short CSTL News CSTL Articles CSTL Message Board
Get CSTL Alerts

News, Short Squeeze, Breakout and More Instantly...
CSTL - Expert Melanoma Panel Recommends Castle Biosciences' DecisionDx®-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma

FRIENDSWOOD, Texas, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of an independent expert consensus paper titled “31-Gene Expression Profiling for Cuta...
CSTL - Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year

FRIENDSWOOD, Texas, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has been recognized by the Houston Chronicle as a Houston Top Workplace, which celebrates people-focu...

CSTL - New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity

FRIENDSWOOD, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating the clinical value of its DecisionDx-Melanoma test in improving sentinel lymph node (S...

CSTL - Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference

FRIENDSWOOD, Texas, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Piper Sandler 37 th Annua...
CSTL - Castle Biosciences Inc. (NASDAQ: CSTL) Sees Notable Increase in Tuesday Morning Market Activity

2025-11-04 09:54:15 ET Castle Biosciences, Inc. (NASDAQ: CSTL) is one of today’s top gainers. The company’s shares have moved 16.43% on the day to $30.26. Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic tes...

CSTL - Castle Biosciences outlines $33B AdvanceAD-Tx market opportunity while raising 2025 revenue guidance

2025-11-03 23:07:07 ET More on Castle Biosciences Castle Biosciences, Inc. (CSTL) Q3 2025 Earnings Call Transcript Castle Biosciences: Strong Margins, Solid Balance Sheet, And Big Upside Potential Seeking Alpha’s Quant Rating on Castle Biosciences Hist...

CSTL - Castle Biosciences, Inc. (CSTL) Q3 2025 Earnings Call Transcript

2025-11-03 23:06:23 ET Castle Biosciences, Inc. (CSTL) Q3 2025 Earnings Call November 3, 2025 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Castle Biosciences, Inc. (CSTL) Q3 2025 Earnings Call Transcript
CSTL - Castle Biosciences Non-GAAP EPS of -$0.02 beats by $0.49, revenue of $83M beats by $11.86M

2025-11-03 16:25:21 ET More on Castle Biosciences Castle Biosciences: Strong Margins, Solid Balance Sheet, And Big Upside Potential Seeking Alpha’s Quant Rating on Castle Biosciences Historical earnings data for Castle Biosciences Financial information...

CSTL - Castle Biosciences Reports Third Quarter 2025 Results

Delivered Q3 2025 revenue of $83 million Q 3 2025 non-dermatologic revenue increased by 67% over Q 3 2024 Q 3 2025 total test reports for our core revenue drivers (DecisionDx ® -Melanoma, TissueCypher ® ) increased ...

CSTL - Castle Biosciences Launches AdvanceAD-Tx(TM) to Help Guide Systemic Treatment Decision Making in Patients with Moderate-to-Severe Atopic Dermatitis

FRIENDSWOOD, Texas, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the launch of AdvanceAD-Tx™, a gene expression profile (GEP) test designed to guide systemic treatment...
Previous 10 Next 10